About us

Sola is a PhD-qualified scientist who has developed, implemented, and commercialised AI-based technologies. A founding member of a leading UK computational drug discovery business, Sola was previously a postdoctoral Research Fellow at Stanford University, School of Engineering, and at Newcastle University, School of Computing Science.

Ed is experienced in yeast genetics, genomics, and evolution. He was a key part of the yeast genome sequencing project, and is now developing tools for exploiting its natural genetic/phenotypic variation. Ed has a PhD in Genetics from The University of California at Berkeley, and a BSc in Biology and Mathematics from Clarkson University.

Chris has over 30 years of industrial experience in yeast strain development for recombinant protein production, and is an inventor on multiple patents. Chris has a PhD in Microbial Genetics from the University of Nottingham, an MSc in Biochemical Engineering (UCL), and a Biotechnology BSc from the University of Leeds.

Andrei is a research scientist and has recently obtained a PhD in Genetics from the University of Leicester. Andrei’s expertise is primarily in yeast genetics and synthetic biology. He currently brings this knowledge to bear on designing and constructing novel strains and genetic constructs.

Johnny has over 20 years of C-suite life sciences leadership. CEO and CFO of multiple biotechnology companies focused on technologies to evaluate complex biology and disease. Led the spin-out of a leading UK computational drug discovery business from Newcastle University, raising over $50 million and taking the company public. A physics and chemistry graduate, a chartered accountant he is also a former investment banker with IPO plus M&A experience.

Steve was formerly involved in the general management of a global leader in prestige beauty as a commercial and marketing director. Previous projects involved commercialising a number of leading brands and designer fragrances across the US, Europe and Nordic countries.

Having gained a BSc in Business Management from the University of Lincoln, Tom now supports and manages business development activities for Phenodynamics. He also takes responsibility for internal and external customer projects.

Mike is a commercially orientated chartered accountant, specialising in managing technical projects and taking the resultant products to market. With significant corporate development experience, he has worked with, and managed, early stage organisations through significant change to commercialise their offerings.